Endovascular Engineering
Latest round
- Series C
Last raised
- Apr 2026
Total raised
- $142M
Investors
- 8
About Endovascular Engineering
Founded in 2019 and Endovascular Engineering, Inc.Endovascular Engineering, Inc. focuses on creating innovative medical technologies aimed at clot removal. The company is headquartered in Menlo Park, US. Mike Rosenthal leads the firm as CEO. In April 2026, Endovascular Engineering, Inc.Endovascular Engineering, Inc. specializes in the development of innovative clot removal technologies, specifically targeting venous thromboembolism. Their flagship product, the Helo™ PE Thrombectomy System, is designed for the effective treatment of pulmonary embolism through a unique self-expanding design that allows for optimal clot engagement with a smaller catheter profile. This technology combines high-speed agitation with physician-controlled aspiration to facilitate the breakdown and removal of clots, providing significant advantages in navigating complex anatomies. The company’s solutions are aimed at healthcare providers, particularly interventional cardiologists and radiologists, who require advanced tools for managing vascular conditions.Endovascular Engineering operates within a business-to-business framework, primarily engaging with hospitals and healthcare institutions that utilize their thrombectomy systems. The company structures its transactions around the sale of medical devices, particularly the Helo™ PE Thrombectomy System, which is currently for investigational use only and not commercially available. Revenue generation is anticipated through partnerships with healthcare providers, focusing on deployment trials and clinical studies. As the company advances its product through the regulatory process, they may also establish pricing plans that align with the needs of their clinical partners, which typically include upfront costs related to device acquisition and potential ongoing service agreements tied to training and support.
Who invested in Endovascular Engineering
8 investors across 4 rounds
See all investors in Endovascular Engineering
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Endovascular Engineering
Who invested in Endovascular Engineering?
Endovascular Engineering has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Endovascular Engineering raised?
Endovascular Engineering has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Endovascular Engineering last raise money?
Endovascular Engineering's most recent round on record is a Series C, in Apr 2026.
What does Endovascular Engineering do?
Founded in 2019 and Endovascular Engineering, Inc.
Where is Endovascular Engineering headquartered?
Endovascular Engineering is headquartered in Menlo Park, US.
Which VCs invest in companies like Endovascular Engineering?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at Endovascular Engineering's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series C
Raising like Endovascular Engineering? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.